No Cafe I’m not. Cash burn is an issue for a lot of bio companies on the ASX. But not many have at least a product they can sell. Oncosil is one of a very few that has that ability. Sure, it has been frustrating and slow but at least it has a CE approval and is in use and being sold. Plenty of bio companies with zero sales, and costly cash burning trials.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.010(0.97%) |
Mkt cap ! $14.50M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.00 | $20.40K | 20.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10319 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 3074 | 1 |
View Market Depth
| Last trade - 10.12am 20/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |